Professor Timo Minssen will give an overview of the Novo Nordisk Foundation Copenhagen-Cambridge-Harvard Inter-CeBIL Programme for International Collaborative Bioscience Innovation and Law, with special emphasis on the quantum part of this pioneering research programme.
